ABRA antibody (Middle Region)
-
- Target See all ABRA Antibodies
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This ABRA antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogen
- ABRA antibody was raised in rabbit using the middle region of ABRA as the immunogen
- Top Product
- Discover our top product ABRA Primary Antibody
-
-
- Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
ABRA Blocking Peptide, catalog no. 33R-7785, is also available for use as a blocking control in assays to test for specificity of this ABRA antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Alternative Name
- ABRA (ABRA Products)
- Synonyms
- STARS antibody, C130068O12Rik antibody, Ms1 antibody, Stars antibody, actin binding Rho activating protein antibody, actin-binding Rho activating protein antibody, ABRA antibody, Abra antibody
- Background
- ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling. Synonyms: Polyclonal ABRA antibody, Anti-ABRA antibody, actin-binding Rho activating protein antibody, STARS antibody.
- Pathways
- Protein targeting to Nucleus
-